2,945
Views
58
CrossRef citations to date
0
Altmetric
Review

An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins

, &
Pages 809-822 | Received 04 Jun 2020, Accepted 13 Jul 2020, Published online: 06 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Katie Pizzolato, David Thacker, Nicole Marie Del Toro-Pagán, Nishita S Amin, Abeer Hanna, Jacques Turgeon & Veronique Michaud. (2022) Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis. Pharmacogenomics and Personalized Medicine 15, pages 943-950.
Read now
Yun Hong, Da-Peng Dai, Jian-Ping Cai, Shuang-Hu Wang, Yi-Ran Wang, Fang-Ling Zhao, Shan Zhou, Quan Zhou, Pei-Wu Geng, Yun-Fang Zhou, Xue Xu, Ji-Hua Shi & Qing-Feng Luo. (2022) Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo. Drug Design, Development and Therapy 16, pages 1779-1789.
Read now
Tamara Božina, Lana Ganoci, Ena Karačić, Livija Šimičević, Majda Vrkić-Kirhmajer, Iva Klarica-Domjanović, Tena Križ, Zrinka Sertić & Nada Božina. (2022) ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population. Annals of Human Biology 49:7-8, pages 323-331.
Read now
Xinjuan Zhang, Jinyao Guo, Jin Li, Chen Chen & Guijun Su. (2022) Pharmacokinetics and pharmacodynamic interaction of bergamottin with atorvastatin in rats. Xenobiotica 52:5, pages 463-467.
Read now
Zeen Tong, Allison Gaudy, Daniel Tatosian, Francisco Ramirez-Valle, Hong Liu, Jian Chen, Matthew Hoffmann & Sekhar Surapaneni. (2021) Assessment of drug-drug interactions of CC-90001, a potent and selective inhibitor of c-Jun N-terminal kinase. Xenobiotica 51:12, pages 1416-1426.
Read now

Articles from other publishers (53)

Fan Wu, Mingyu Cui, Siwen Wang, Chao Yu, Weihong Yin, Jiao Li & Xueying Yan. (2023) Effect of Berberine on Pharmacokinetics and Pharmacodynamics of Atorvastatin in Hyperlipidemia Rats. Xenobiotica, pages 1-27.
Crossref
Catriona Halliday, Hannah Yejin Kim, Enoch Tay, Sharon C A Chen & Jan-Willem Alffenaar. (2023) Exploring synergy between azole antifungal drugs and statins for Candida auris . Journal of Antimicrobial Chemotherapy 78:12, pages 2824-2829.
Crossref
Mei Jin, Jian Fang, Jiao-jiao Wang, Xin Shao, Suo-wen Xu, Pei-qing Liu, Wen-cai Ye & Zhi-ping Liu. (2023) Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics. Acta Pharmacologica Sinica 44:12, pages 2358-2375.
Crossref
Shi Zhong, Yanan Yang, Jinxi Huo, Yuqing Sun, Ning Ren, Qinhua Lu, Da Li, Pengfei Zhan, Weijie Wu, Huizhi Chen, Ben Niu, Meiliang Pan, Huanyan Ma, Qinqiao Liu, Qingsheng Li, Chongming Wu & Yougui Li. (2023) Dissection of gut microbiota and metabolites reveals the hypolipidemic effect of green mulberry leaf tea / black mulberry leaf tea in mice. Journal of Functional Foods 111, pages 105906.
Crossref
Yu Li, Qin Huang, Xianghai Zeng, Rong Wang & Wenbin Li. (2023) Population Pharmacokinetics of Atorvastatin in High‐Altitude and Plain Patients with Hyperlipidemic. The Journal of Clinical Pharmacology.
Crossref
Zizo LusikiDirk BlomNyarai D. Soko, Smangele MalemaErika JonesBrian RaynerJonathan BlackburnPhumla SinxadiMichelle T. DandaraCollet Dandara. (2023) Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens. OMICS: A Journal of Integrative Biology.
Crossref
Orsolya Ungvári, Éva Bakos, Daniella Kovacsics & Csilla Özvegy‐Laczka. (2023) The fluorescence‐based competitive counterflow assay developed for organic anion transporting polypeptides 1A2 , 1B1 , 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate . The FASEB Journal 37:11.
Crossref
Ninoslava Lalatović, Maša Ždralević, Tanja Antunović & Snežana Pantović. (2023) Genetic polymorphisms in ABCB1 are correlated with the increased risk of atorvastatin-induced muscle side effects: a cross-sectional study. Scientific Reports 13:1.
Crossref
Ziyang Shan, Xuemei Yang, Huihui Liu, Yafei Yuan, Yuan Xiao, Jing Nan, Wei Zhang, Wenqi Song, Jufang Wang, Feiwen Wei & Yanqing Zhang. (2023) Cryo-EM structures of human organic anion transporting polypeptide OATP1B1. Cell Research 33:12, pages 940-951.
Crossref
Siaw Wee Teo, Theresa Hayes & James Gome. (2023) Ribociclib may potentiate rosuvastatin effect in causing late onset rhabdomyolysis. BMJ Case Reports 16:9, pages e255632.
Crossref
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, Andrew Rowland & Robyn Meech. (2023) Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance. Pharmacology & Therapeutics 248, pages 108459.
Crossref
Ji-Yao Sheng, Zi-Fan Meng, Qiao Li & Yong-Sheng Yang. (2023) Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension. Hepatobiliary & Pancreatic Diseases International.
Crossref
Nam Kyung Je, Sangsu Youm & Pusoon Chun. (2023) Real world co‐prescribing contraindicated drugs with fluconazole and itraconazole. Pharmacoepidemiology and Drug Safety 32:7, pages 752-762.
Crossref
Carlos Fernando Araujo-Lima, Rita de Cassia Castro Carvalho, Sandra Loureiro Rosario, Debora Inacio Leite, Anna Caroline Campos Aguiar, Lizandra Vitoria de Souza Santos, Julianna Siciliano de Araujo, Kelly Salomão, Carlos Roland Kaiser, Antoniana Ursine Krettli, Monica Macedo Bastos, Claudia Alessandra Fortes Aiub, Maria de Nazaré Correia Soeiro, Nubia Boechat & Israel Felzenszwalb. (2023) Antiplasmodial, Trypanocidal, and Genotoxicity In Vitro Assessment of New Hybrid α,α-Difluorophenylacetamide-statin Derivatives. Pharmaceuticals 16:6, pages 782.
Crossref
Justine Keathley, Jessica White & Gregor Reid. (2023) The Impact of Nutrition, Physical Activity, Beneficial Microbes, and Fecal Microbiota Transplant for Improving Health. Life 13:5, pages 1124.
Crossref
Markus Hovd, Ida Robertsen, Line Kristin Johnson, Veronica Krogstad, Christine Wegler, Kine Eide Kvitne, Marianne Kristiansen Kringen, Eva Skovlund, Cecilia Karlsson, Shalini Andersson, Per Artursson, Rune Sandbu, Jøran Hjelmesæth, Anders Åsberg, Rasmus Jansson-Löfmark & Hege Christensen. (2023) Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance. Clinical Pharmacokinetics 62:5, pages 725-735.
Crossref
François Boujonnier, Florian Lemaitre & Lucie-Marie Scailteux. (2023) Pharmacokinetic Interactions Between Abiraterone, Apalutamide, Darolutamide or Enzalutamide and Antithrombotic Drugs: Prediction of Clinical Events and Review of Pharmacological Information. Cardiovascular Drugs and Therapy.
Crossref
A.D. Rodrigues. (2022) Reimagining the Framework Supporting the Static Analysis of Transporter Drug Interaction Risk; Integrated Use of Biomarkers to Generate Pan‐Transporter Inhibition Signatures . Clinical Pharmacology & Therapeutics 113:5, pages 986-1002.
Crossref
Ana Salomé Correia, Lara Marques & Nuno Vale. (2023) The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current Issues in Molecular Biology 45:4, pages 3333-3346.
Crossref
Koichiro Adachi, Katsuhiro Ohyama, Yoichi Tanaka, Tasuku Sato, Norie Murayama, Makiko Shimizu, Yoshiro Saito & Hiroshi Yamazaki. (2023) High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database. Drug Metabolism and Pharmacokinetics 49, pages 100486.
Crossref
Aftab Ahmad, Unnikrishnan Meenakshi Dhanalekshmi, Kailasam Koumaravelu, Arul Prakash Francis, Shah Alam Khan, Mohammed F. Abuzinadah & Nandakumar Selvasudha. (2023) A Study on Pharmacokinetic Functionalities and Safety Margins of an Optimized Simvastatin Nanoformulation. Pharmaceuticals 16:3, pages 380.
Crossref
Zebin Jiang, Zemin Wu, Ruixue Liu, Qin Du, Xian Fu, Min Li, Yongjun Kuang, Shen Lin, Jiaxuan Wu, Weiji Xie, Ganggang Shi, Yanqiang Peng & Fuchun Zheng. (2023) Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease. Frontiers in Pharmacology 14.
Crossref
Rebecca Oyetoro, Layton Wiemer, Olgert Bardhi, Mariam Louis & Rafik Jacob. (2023) Special Considerations for Management of Diabetes in Adult Patients with Intellectual and Developmental Disabilities. Advances in Medicine 2023, pages 1-11.
Crossref
P. D. Erokhina, A. A. Slepnev, P. Yu. Mylnikov, S. O. Ganina, E. A. Konyakhin, A. V. Shchulkin & E. N. Yakusheva. (2023) HepG2 cell line as a model for studying of the statins’ hepatic uptake. Experimental and Clinical Gastroenterology:10, pages 70-76.
Crossref
Massimiliano Ruscica, Nicola Ferri, Maciej Banach, Cesare R Sirtori & Alberto Corsini. (2022) Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications. Cardiovascular Research 118:17, pages 3288-3304.
Crossref
Jin A Lee, Seong-Soo Roh, Woo Rak Lee & Mi-Rae Shin. (2023) Effect of hemp seed oil on lipid metabolism in rats fed a high-cholesterol diet. Journal of Nutrition and Health 56:4, pages 361.
Crossref
Bruce A. Warden, John R. Guyton, Adrienne C. Kovacs, Jessica A. Durham, Laney K. Jones, Dave L. Dixon, Terry A. Jacobson & P. Barton Duell. (2023) Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association. Journal of Clinical Lipidology 17:1, pages 19-39.
Crossref
Yolanda Prado, Diego Aravena, Felipe M. Llancalahuen, Cristobal Aravena, Felipe Eltit, Cesar Echeverría, Sebastian Gatica, Claudia A. Riedel & Felipe Simon. 2023. Advances in Molecular Pathology. Advances in Molecular Pathology 25 47 .
A. Muñoz-Blanco, R. Gómez-Huelgas & J.F. Gómez-Cerezo. (2022) Statin-associated muscle symptoms: Myth or reality?. Revista Clínica Española (English Edition) 222:10, pages 602-611.
Crossref
A. Muñoz-Blanco, R. Gómez-Huelgas & J.F. Gómez-Cerezo. (2022) Sintomatología muscular asociada a estatinas: ¿mito o realidad?. Revista Clínica Española 222:10, pages 602-611.
Crossref
He Li, Yawei Du, Hanrui Ji, Yanan Yang, Changchang Xu, Qiaodan Li, Longkai Ran, Chongming Wu, Qile Zhou & Shengxian Wu. (2022) Adenosine-rich extract of Ganoderma lucidum: A safe and effective lipid-lowering substance. iScience 25:11, pages 105214.
Crossref
Sukhbir Singh, Ishrat Zahoor, Neelam Sharma, Tapan Behl, Neha Kanojia, Aayush Sehgal, Syam Mohan, Yosif Almoshari, Ahmad Salawi, Lotfi Aleya & Simona Bungau. (2022) Insights into the pivotal role of statins and its nanoformulations in hyperlipidemia. Environmental Science and Pollution Research 29:51, pages 76514-76531.
Crossref
Ines Villano, Marco La Marra, Salvatore Allocca, Ciro Rosario Ilardi, Rita Polito, Chiara Porro, Sergio Chieffi, Giovanni Messina, Vincenzo Monda, Girolamo Di Maio & Antonietta Messina. (2022) The Role of Nutraceutical Supplements, Monacolin K and Astaxanthin, and Diet in Blood Cholesterol Homeostasis in Patients with Myopathy. Biomolecules 12:8, pages 1118.
Crossref
Alipio Mangas, Alexandra Pérez-Serra, Fernando Bonet, Ovidio Muñiz, Francisco Fuentes, Aurora Gonzalez-Estrada, Oscar Campuzano, Juan Sebastian Rodriguez Roca, Elena Alonso-Villa & Rocio Toro. (2022) A microRNA Signature for the Diagnosis of Statins Intolerance. International Journal of Molecular Sciences 23:15, pages 8146.
Crossref
Amanda J Berberich & Robert A Hegele. (2022) A Modern Approach to Dyslipidemia. Endocrine Reviews 43:4, pages 611-653.
Crossref
Carlos Moctezuma-Velazquez & Juan Gonzalez Abraldes. (2022) The Role of Statins in Cirrhosis. Current Treatment Options in Gastroenterology 20:3, pages 316-335.
Crossref
Chang Liu, Rui Ma, Daifeng Gao, Bin Hu, Xiaolei Yin, Zhipeng Liu, Hu Lin & Zhenhua Zhang. (2022) Investigation of Statin Medication Use in Elderly Patients with Cardiovascular Disease on Regular Physical Examination and the Relationship with Glucolipid Metabolism and Adverse Cardiovascular Prognosis. Disease Markers 2022, pages 1-5.
Crossref
Algera Goga & Markus Stoffel. (2022) Therapeutic RNA-silencing oligonucleotides in metabolic diseases. Nature Reviews Drug Discovery 21:6, pages 417-439.
Crossref
Michel Grosse, Kerstin Günther, Paul M. Jordan, Dávid Roman, Oliver Werz & Christine Beemelmanns. (2022) Synthesis of Functionalized δ‐Hydroxy‐β‐keto Esters and Evaluation of Their Anti‐inflammatory Properties. ChemBioChem 23:9.
Crossref
Kazuya Maeda & Yuichi Sugiyama. 2022. Drug Transporters. Drug Transporters 453 474 .
Qi Zhang, Hang Qu, Yinghui Chen, Xueyang Luo, Chong Chen, Bing Xiao, Xiaowei Ding, Pengjun Zhao, Yanan Lu, Alex F. Chen & Yu Yu. (2022) Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT/GPx4 Axis. Frontiers in Cell and Developmental Biology 10.
Crossref
Gabriel Stillemans, Adrien Paquot, Giulio G. Muccioli, Emilia Hoste, Nadtha Panin, Anders Åsberg, Jean‐Luc Balligand, Vincent Haufroid & Laure Elens. (2021) Atorvastatin population pharmacokinetics in a real‐life setting: Influence of genetic polymorphisms and association with clinical response. Clinical and Translational Science 15:3, pages 667-679.
Crossref
Guofei Li, Mingming Zhao & Limei Zhao. (2022) The drug interaction potential of berberine hydrochloride when co-administered with simvastatin, fenofibrate, gemfibrozil, metformin, glimepiride, nateglinide, pioglitazone and sitagliptin in beagles. Arabian Journal of Chemistry 15:2, pages 103562.
Crossref
Carolina Dagli-Hernandez, Yitian Zhou, Volker Martin Lauschke, Fabiana Dalla Vecchia Genvigir, Thiago Dominguez Crespo Hirata, Mario Hiroyuki Hirata & Rosario Dominguez Crespo Hirata. (2021) Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts. Pharmacological Reports 74:1, pages 47-66.
Crossref
Speranta Iacob, Susanne Beckebaum, Razvan Iacob, Cristian Gheorghe, Vito Cicinnati, Irinel Popescu & Liana Gheorghe. (2022) Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation. Frontiers in Nutrition 8.
Crossref
Bob M. MooreIIII & George A. Cook. 2022. Cholesterol. Cholesterol 903 926 .
Mingyu Cui, Fengmei Zhu, Yifeng Yin, Yue Sui, Xueying Yan & Tingting Chen. (2021) Influence of Gegenqinlian Decoction on Pharmacokinetics and Pharmacodynamics of Atorvastatin Calcium in Hyperlipidemic Rats. European Journal of Drug Metabolism and Pharmacokinetics 47:1, pages 117-126.
Crossref
Mohamed‐Eslam F. Mohamed, Sheryl Coppola, Tian Feng, Heidi S. Camp, Elaine Kim & Ahmed A. Othman. (2021) Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects. Clinical Pharmacology in Drug Development 10:11, pages 1335-1344.
Crossref
Brian Lu, Laura Sun, Manuel Seraydarian, Thomas J. Hoffmann, Marisa W. Medina, Neil Risch, Carlos Iribarren, Ronald M. Krauss & Akinyemi Oni‐Orisan. (2021) Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin . Clinical Pharmacology & Therapeutics 110:3, pages 733-740.
Crossref
Yue Xiang, Hideaki Okochi, Ivan Kozachenko, Jasleen K. Sodhi, Lynda A. Frassetto & Leslie Z. Benet. (2021) Effects of Single Dose Rifampin on the Pharmacokinetics of Fluvastatin in Healthy Volunteers. Clinical Pharmacology & Therapeutics 110:2, pages 480-485.
Crossref
Nada Božina, Lana Ganoci, Livija Simičević, Katarina Gvozdanović, Iva Klarica Domjanović, Margareta Fistrek Prlić, Tena Križ, Ana Borić Bilušić, Mario Laganović & Tamara Božina. (2021) Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review. Archives of Industrial Hygiene and Toxicology 72:2, pages 114-128.
Crossref
Joana Rita Chora & Mafalda Bourbon. (2021) Pharmacogenomics of statins and familial hypercholesterolemia. Current Opinion in Lipidology 32:2, pages 96-102.
Crossref
Christopher Murphy, Evelyne Deplazes, Charles G. Cranfield & Alvaro Garcia. (2020) The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins. International Journal of Molecular Sciences 21:22, pages 8745.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.